Publication Beamlines Strategic Pillar
(2015). ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE. Patent Number: AR093446A1.
(2020). ANTI-BCMA ANTIBODIES, BIESPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND THEIR USES. Patent Number: PT3337824T.
(2025). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL298041B2.
(2015). Novel TNFa structure for use in therapy. Patent Number: GB201510758D0.